Supplementary Table S1 from Long Noncoding RNA Pancets-1 Promotes Neuroblastoma Progression Through Hnrnpk-Mediated Β-Catenin Stabilization

Dan Li,Xiaojing Wang,Maochun Hong,Erhu Fang,Lin Ye,Huajie Song,Yijun Feng,Huanhuan Li,Kai Huang,Liduan Zheng,Qiangsong Tong

DOI: https://doi.org/10.1158/0008-5472.22412048

2023-01-01

Abstract:Table S1 shows primer sets used for RACE, qRT-PCR, RIP, probe, and ChIP

What problem does this paper attempt to address?

Supplementary Table S2 from Long Noncoding RNA Pancets-1 Promotes Neuroblastoma Progression Through Hnrnpk-Mediated Β-Catenin Stabilization

Dan Li,Xiaojing Wang,Maochun Hong,Erhu Fang,Lin Ye,Huajie Song,Yijun Feng,Huanhuan Li,Kai Huang,Liduan Zheng,Qiangsong Tong

DOI: https://doi.org/10.1158/0008-5472.22412045

2023-01-01

Abstract:Table S2 shows oligonucleotide sets used for constructs and short hairpin RNAs
Supplementary Figure S1-S5 from Long Noncoding RNA Pancets-1 Promotes Neuroblastoma Progression Through Hnrnpk-Mediated Β-Catenin Stabilization

Dan Li,Xiaojing Wang,Maochun Hong,Erhu Fang,Lin Ye,Huajie Song,Yijun Feng,Huanhuan Li,Kai Huang,Liduan Zheng,Qiangsong Tong

DOI: https://doi.org/10.1158/0008-5472.22412051

2023-01-01

Abstract:Figure S1 shows the schematic positions for primers; Figure S2 shows the characterization of a novel lncRNA pancEts-1; Figure S3 shows the expression and Kaplan-Meier survival curves of pancEts-1 downstream genes; Figure S4 shows the expression of β-catenin and hnRNPK in NB cells; Figure S5 shows the roles of pancEts-1 in facilitating the β-catenin activity and downstream gene expression in NB cells.
Supplementary Tables from LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen–Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation

Chongbiao Huang,Yang Li,Zengxun Li,Yang Xu,Na Li,Yi Ge,Jie Dong,Antao Chang,Tiansuo Zhao,Xiuchao Wang,Hongwei Wang,Shengyu Yang,Keping Xie,Jihui Hao,He Ren

DOI: https://doi.org/10.1158/1078-0432.22470555

2023-01-01

Abstract:7 Supplementary Tables: Supplementary Table S1. Association between LIMS1 expression and clinicopathological features of patients with PDAC. Supplementary Table S2. Association between LIMS1 mRNA expression and clinicopathological features of PDAC patients from TCGA. Supplementary Table S3. Cox's proportional hazards model analysis of prognostic factors in patients with pancreatic ductal adenocarcinoma (PDAC) Supplementary Table S4. Association between LIMS1 expression and clinicopathological features of patients with esophageal cancer. Supplementary Table S5. Association between LIMS1 expression and clinicopathological features of patients with lung adenocarcinoma. Supplementary Table S6. Main antibodies and reagents. Supplementary Table S7. Primers and oligonucleotides sequences.
Supplementary Table 7-10 from Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2

Qun Chen,Jinquan Cai,Qixue Wang,Yunfei Wang,Mingyang Liu,Jingxuan Yang,Junhu Zhou,Chunsheng Kang,Min Li,Chuanlu Jiang

DOI: https://doi.org/10.1158/1078-0432.22464858

2023-01-01

Abstract:Supplementary Table 7. Sequences of sgRNA and siRNA Supplementary Table 8. HOTAIR 5'mut and NEAT1 probe sequence Supplementary Table 9. PCR primer sequences Supplementary Table 10. Sequences of biotin probes
Supplementary Table 1-4 from Long Noncoding RNA neat1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2

Qun Chen,Jinquan Cai,Qixue Wang,Yunfei Wang,Mingyang Li,Jingxuan Yang,Junhu Zhou,Chunsheng Kang,Min Li,Chuanlu Jiang

DOI: https://doi.org/10.1158/1078-0432.22464864.v1

2023-01-01

Abstract:Supplementary Table 1. The characteristics of CGGA database. Supplementary Table 2. The characteristics of Rembrandt database. Supplementary Table 3. The characteristics of TCGA database. Supplementary Table 4. The characteristics of GSE16011 database.
Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395236.v1

2023-01-01

Abstract:Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419831

2023-01-01

Abstract:Supplementary Table S1. Primers for qRT-PCR and MSP
Long Noncoding RNA LCAT1 Functions As a Cerna to Regulate RAC1 Function by Sponging Mir-4715-5p in Lung Cancer

Juze Yang,Qiongzi Qiu,Xinyi Qian,Jiani Yi,Yiling Jiao,Mengqian Yu,Xufan Li,Jia Li,Chunyi Mi,Jisong Zhang,Bingjian Lu,Enguo Chen,Pengyuan Liu,Yan Lu

DOI: https://doi.org/10.1186/s12943-019-1107-y

IF: 37.3

2019-01-01

Molecular Cancer

Abstract:Abstract Introduction Long noncoding RNAs (lncRNAs) are emerging as key players in the development and progression of cancer. However, the biological role and clinical significance of most lncRNAs in lung carcinogenesis remain unclear. In this study, we identified and explored the role of a novel lncRNA, lung cancer associated transcript 1 (LCAT1), in lung cancer. Methods We predicted and validated LCAT1 from RNA-sequencing (RNA-seq) data of lung cancer tissues. The LCAT1–miR-4715-5p–RAC1 axis was assessed by dual-luciferase reporter and RNA immunoprecipitation (RIP) assays. Signaling pathways altered by LCAT1 knockdown were identified using RNA-seq. Furthermore, the mechanism of LCAT1 was investigated using loss-of-function and gain-of-function assays in vivo and in vitro. Results LCAT1 is an oncogene that is significantly upregulated in lung cancer tissues and associated with poor prognosis. LCAT1 knockdown caused growth arrest and cell invasion in lung cancer cells in vitro, and inhibited tumorigenesis and metastasis in the mouse xenografts. Mechanistically, LCAT1 functions as a competing endogenous RNA for miR-4715-5p, thereby leading to the upregulation of the activity of its endogenous target, Rac family small GTPase 1 (RAC1). Moreover, EHop-016, a small molecule inhibitor of RAC1, as an adjuvant could improve the Taxol monotherapy against lung cancer cells in vitro. Conclusions LCAT1–miR-4715-5p–RAC1/PAK1 axis plays an important role in the progression of lung cancer. Our findings may provide valuable drug targets for treating lung cancer. The novel combination therapy of Taxol and EHop-016 for lung cancer warrants further investigation, especially in lung cancer patients with high LCAT1 expression.
Supplementary Table 1 from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by LKB1 Loss

Yan Feng,Ye Wang,Zuoyun Wang,Zhaoyuan Fang,Fei Li,Yijun Gao,Hongyan Liu,Tian Xiao,Fuming Li,Yang Zhou,Qiwei Zhai,Xiaolong Liu,Yihua Sun,Nabeel Bardeesy,Kwok-kin Wong,Haiquan Chen,Zhi-qi Xiong,Hongbin Ji

DOI: https://doi.org/10.1158/0008-5472.22395500.v1

2023-01-01

Abstract:PDF file - 139K, The list of primers used in this study
A Novel Neutrophil Extracellular Traps-Related Lncrna Signature Predicts Prognosis in Patients with Early-Stage Lung Adenocarcinoma

Huan Wang,Yueli Shi,Xia Xu,Shumin Xu,Yuting Shi,Weiyu Chen,Kai Wang

DOI: https://doi.org/10.1080/07853890.2023.2279754

2023-01-01

Abstract:Background Neutrophil extracellular traps (NETs) could entrap tumour cells and promote their dissemination and metastasis. Further analysis of NETs-related molecules is expected to provide a new strategy for prognosis prediction and treatment of lung adenocarcinoma (LUAD) patients.Methods The model construction was established through co-expression analysis, Lasso Cox regression, univariate and multivariate COX regression, Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway. The potential drugs and analysed drug sensitivity were screened by pRRophetic packages.Results In this study, we constructed a 15 NETs-related long non-coding RNAs (lncRNAs) prognostic prediction model (AC091057.1, SPART-AS1, AC023796.2, AL031600.2, AC084781.1, AC032011.1, FAM66C, C026355.2, AL096870.2, AC092718.5, PELATON, AC008635.1, AL162632.3, AC087501.4 and AC123768.3) for patients with early-stage LUAD based on public databases and datasets. The signature is associated with immune cell functions, tumour mutation burden and treatment sensitivity in LUAD patients. Additionally, we found that FAM66C is highly expressed in lung cancer patients for the first time, which is associated with poor prognosis. FAM66C knockdown significantly inhibited the proliferation and migration ability of the tumour cells.Conclusions In conclusion, this model is a new and effective prognostic and efficacy predictive biomarker, FAM66C plays an oncogene role in the process of LUAD development. It may provide a new theoretical basis for the clinical diagnosis and treatment in LUAD patients in early stage.
Supplementary Table 4 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Xiaowen Shao,Yamei Dang,Tingting Zhang,Nan Bai,Jianing Huang,Mengya Guo,Li Sun,Minghe Li,Xiao Sun,Xinran Zhang,Feng Han,Ning Zhang,Hao Zhuang,Yongmei Li

DOI: https://doi.org/10.1158/1541-7786.25325111.v1

2024-01-01

Abstract:Sequences of the DNA primers for RT-qPCR and in vitro transcription, and the sequences of LINC00869 probes.
Supplementary Table 1 from RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma

Xuebo Chen,Leying Zhang,Ian Y. Zhang,Junling Liang,Huaqing Wang,Mao Ouyang,Shihua Wu,Anna Carolina Carvalho da Fonseca,Lihong Weng,Yasuhiko Yamamoto,Hiroshi Yamamoto,Rama Natarajan,Behnam Badie

DOI: https://doi.org/10.1158/0008-5472.22402854

2023-01-01

Abstract:Supplementary Table 1: Primers used in the real-time quantitative PCR.
The Long Noncoding RNA Lncnb1 Promotes Tumorigenesis by Interacting with Ribosomal Protein RPL35

Pei Y. Liu,Andrew E. Tee,Giorgio Milazzo,Katherine M. Hannan,Jesper Maag,Sujanna Mondal,Bernard Atmadibrata,Nenad Bartonicek,Hui Peng,Nicholas Ho,Chelsea Mayoh,Roberto Ciaccio,Yuting Sun,Michelle J. Henderson,Jixuan Gao,Celine Everaert,Amy J. Hulme,Matthew Wong,Qing Lan,Belamy B. Cheung,Leming Shi,Jenny Y. Wang,Thorsten Simon,Matthias Fischer,Xu D. Zhang,Glenn M. Marshall,Murray D. Norris,Michelle Haber,Jo Vandesompele,Jinyan Li,Pieter Mestdagh,Ross D. Hannan,Marcel E. Dinger,Giovanni Perini,Tao Liu

DOI: https://doi.org/10.1038/s41467-019-12971-3

IF: 16.6

2019-01-01

Nature Communications

Abstract:The majority of patients with neuroblastoma due to MYCN oncogene amplification and consequent N-Myc oncoprotein over-expression die of the disease. Here our analyses of RNA sequencing data identify the long noncoding RNA lncNB1 as one of the transcripts most overexpressed in MYCN-amplified, compared with MYCN-non-amplified, human neuroblastoma cells and also the most over-expressed in neuroblastoma compared with all other cancers. lncNB1 binds to the ribosomal protein RPL35 to enhance E2F1 protein synthesis, leading to DEPDC1B gene transcription. The GTPase-activating protein DEPDC1B induces ERK protein phosphorylation and N-Myc protein stabilization. Importantly, lncNB1 knockdown abolishes neuroblastoma cell clonogenic capacity in vitro and leads to neuroblastoma tumor regression in mice, while high levels of lncNB1 and RPL35 in human neuroblastoma tissues predict poor patient prognosis. This study therefore identifies lncNB1 and its binding protein RPL35 as key factors for promoting E2F1 protein synthesis, N-Myc protein stability and N-Myc-driven oncogenesis, and as therapeutic targets.
Figure S1-8 from Long Noncoding RNA neat1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2

Qun Chen,Jinquan Cai,Qixue Wang,Yunfei Wang,Mingyang Li,Jingxuan Yang,Junhu Zhou,Chunsheng Kang,Min Li,Chuanlu Jiang

DOI: https://doi.org/10.1158/1078-0432.22464870

2023-01-01

Abstract:Supplementary Figure 1. NEAT1 is a potential EGFR-driven lncRNA, as demonstrated through bioinformatics analysis, and the status of EGFR (or EGFRvIII), p53, PDGFR in patient-derived cells are validated by Western blot. Supplementary Figure 2. NEAT1 is an abundant nuclear lncRNA that could be knocked down through the dual CRISPR/Cas9 system in glioblastoma cells. Supplementary Figure 3. Knockdown of NEAT1 inhibits proliferation, invasion and clone formation and induces cell apoptosis in glioblastoma cells. Supplementary Figure 4. Knockdown of NEAT1 promotes WNT/β-Catenin negative feedback factor expression in N5 and N9 cells. Supplementary Figure 5. Knockdown of NEAT1 level inhibits β-Catenin in N5 and N9 cells. Supplementary Figure 6. The correlation analysis among DNA methylation, DNA copy number and NEAT1 expression profiles in TCGA GBM database. Supplementary Figure 7. NEAT1 is an evolutionarily conserved lncRNA and may bind to EZH2. Supplementary Figure 8. NEAT1 does not bind with DNMT1; the expression of NEAT1_1, NEAT1_2 and MALAT1 are detected when glioblastoma cells were treated with HOTAIR associated virus, and the H3K27Me3 level in different NEAT1 treatment groups is detected.
Supplementary Tables from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

Tao Yu,Yingjun Zhao,Zhixiang Hu,Jing Li,Dandan Chu,Jiwei Zhang,Zhe Li,Bing Chen,Xiao Zhang,Hongyu Pan,Shengli Li,Hechun Lin,Lei Liu,Mingxia Yan,Xianghuo He,Ming Yao

DOI: https://doi.org/10.1158/0008-5472.22418429.v1

2023-01-01

Abstract:Several tables contain the nucleotide sequences, antibodies information, LncRNA expression profiles, LncRNA screening, the correlation between MetaLnc9 and clinicopathological features, the mass spectrometric analysis results, RNA-seq analysis, KEGG and GSEA analysis.
Supplementary Table 3 from Long Noncoding RNA ANRIL Promotes Non–Small Cell Lung Cancer Cell Proliferation and Inhibits Apoptosis by Silencing KLF2 and P21 Expression

Feng-qi Nie,Ming Sun,Jin-song Yang,Min Xie,Tong-peng Xu,Rui Xia,Yan-wen Liu,Xiang-hua Liu,Er-bao Zhang,Kai-hua Lu,Yong-qian Shu

DOI: https://doi.org/10.1158/1535-7163.22501533.v1

2023-01-01

Abstract:Supplementary table 3. Sequence of primers and siRNA
The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation.

Gaurav Kumar Pandey,Sanhita Mitra,Santhilal Subhash,Falk Hertwig,Meena Kanduri,Kankadeb Mishra,Susanne Fransson,Abiarchana Ganeshram,Tanmoy Mondal,Sashidhar Bandaru,Malin Ostensson,Levent M Akyürek,Jonas Abrahamsson,Susan Pfeifer,Erik Larsson,Leming Shi,Zhiyu Peng,Matthias Fischer,Tommy Martinsson,Fredrik Hedborg,Per Kogner,Chandrasekhar Kanduri

DOI: https://doi.org/10.1016/j.ccell.2014.09.014

IF: 50.3

2014-01-01

Cancer Cell

Abstract:Neuroblastoma is an embryonal tumor of the sympathetic nervous system and the most common extracranial tumor of childhood. By sequencing transcriptomes of low- and high-risk neuroblastomas, we detected differentially expressed annotated and nonannotated long noncoding RNAs (lncRNAs). We identified a lncRNA neuroblastoma associated transcript-1 (NBAT-1) as a biomarker significantly predicting clinical outcome of neuroblastoma. CpG methylation and a high-risk neuroblastoma associated SNP on chromosome 6p22 functionally contribute to NBAT-1 differential expression. Loss of NBAT-1 increases cellular proliferation and invasion. It controls these processes via epigenetic silencing of target genes. NBAT-1 loss affects neuronal differentiation through activation of the neuronal-specific transcription factor NRSF/REST. Thus, loss of NBAT-1 contributes to aggressive neuroblastoma by increasing proliferation and impairing differentiation of neuronal precursors.
Supplementary Data 1 from an LTR Retrotransposon-Derived Long Noncoding RNA Lncmer52a Promotes Hepatocellular Carcinoma Progression by Binding P120-Catenin

Yangjun Wu,Yiming Zhao,Lin Huan,Jingjing Zhao,Yuqiang Zhou,Linguo Xu,Zhixiang Hu,Yizhe Liu,Zhiao Chen,Lu Wang,Shenglin Huang,Xianghuo He,Linhui Liang

DOI: https://doi.org/10.1158/0008-5472.22424334.v1

2023-01-01

Abstract:Full scan of all the western blots in the main figures.
High-throughput screening identifies non-coding RNA PANC246 as a novel pan-tumor suppressor ncRNA

丁伟峰,张健锋,常仁安,叶敬新,郭士成,曹桂莲

DOI: https://doi.org/10.3760/cma.j.cn421213-20201229-00963

2021-01-01

Abstract:Objective:Non-coding RNA exerted key roles in the occurrence and development of tumors. However, ncRNAs with tumor extensively-suppressing roles were largely undefined. The purpose of this study is to find novel tumor-suppressing ncRNAs and confirm their function by bio-informatics and in vitro experiments.Methods:We applied the genome-widemeta analysis to the pan-cancer RNA-sequencing data across 23 human cancers in The Cancer Genome Atlas (TCGA) database, and screen novel down-regulated pan-cancer ncRNAs. We next performed in vitro experiments including CCK-8, cell migration, Transwell invasion and cell apoptosis to confirm its pan-cancer suppression roles. Bilateral t test was used for comparison between two groups. Results:In this research, we found 1615 differential-expressed ncRNAs. Among these, a novel ncRNA were identified, which encoded by ENSG00000231246 and we nominated it as PAn-cancer Non-Coding RNA 246 (PANC246). Compared to untransfected group and pcDNA3.1 plasmid group, over-expression of PANC246 significantly inhibited the ability of cell proliferation ( t=7.252, P<0.01), migration ( t=15.073, P<0.01) and invasion ( t=11.003, P<0.01), whilst it significantly increased the apoptosis of tumor cells ( t=23.293, P<0.01). Furthermore, up-regulated PANC246 significantly down-regulated the mRNA levels of the related oncogenes, such as CDK2 ( t=19.301, P<0.01), KRAS ( t=14.682, P<0.01), and MUC16 ( t=22.581, P<0.01). Conclusion:PANC246 was a novel pan-cancer suppressor which may be a potential therapeutic target.
Supplementary files from An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin

Yangjun Wu,Yiming Zhao,Lin Huan,Jingjing Zhao,Yuqiang Zhou,Linguo Xu,Zhixiang Hu,Yizhe Liu,Zhiao Chen,Lu Wang,Shenglin Huang,Xianghuo He,Linhui Liang

DOI: https://doi.org/10.1158/0008-5472.22424325

2023-01-01

Abstract:Supplementary data-The Supplementary information includes: Figure S1. The genomic location, subcellular distribution, full length and coding potential of lncMER52A. Figure S2. The knockdown efficiency and specificity of lncMER52A siRNAs and Crispr-Cas9 mediated knockdown. The effects of lncMER52A on the migration, invasion and metastasis of HCC cells. Figure S3. The correlation of lncMER52A and p120-catenin in HCC tissues and paired normal livers. Figure S4. lncMER52A overexpression significantly inhibited the interaction between β-TrCP1 and p120-catenin. Figure S5. The effects of p120-catenin on the migration and invasion of HCC cells in vitro. Figure S6. H3K4me3 and H3K27ac levels at the promoter of lncMER52A in Huh7 and HepG2-C3A cells. Table S1. Primers for RACE assays. Table S2. Sequence of siRNAs and gRNAs. Table S3. Primers used in molecular cloning of vectors. Table S4. Primers used in the RNA pulldown assays. Table S5. Primers used in the northern blot assays. Table S6. Primers used in the qPCR experiments. Table S7. Primers used in the ChIP assays. Table S8. The correlation of lncMER52A expression with HCC. clinicopathological features.

Supplementary Table S1 from Long Noncoding RNA Pancets-1 Promotes Neuroblastoma Progression Through Hnrnpk-Mediated Β-Catenin Stabilization

Supplementary Table S2 from Long Noncoding RNA Pancets-1 Promotes Neuroblastoma Progression Through Hnrnpk-Mediated Β-Catenin Stabilization

Supplementary Figure S1-S5 from Long Noncoding RNA Pancets-1 Promotes Neuroblastoma Progression Through Hnrnpk-Mediated Β-Catenin Stabilization

Supplementary Tables from LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen–Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation

Supplementary Table 7-10 from Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2

Supplementary Table 1-4 from Long Noncoding RNA <i>neat1</i>, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/<b>β</b>-Catenin Pathway by Scaffolding EZH2

Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Long Noncoding RNA LCAT1 Functions As a Cerna to Regulate RAC1 Function by Sponging Mir-4715-5p in Lung Cancer

Supplementary Table 1 from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by <i>LKB1</i> Loss

A Novel Neutrophil Extracellular Traps-Related Lncrna Signature Predicts Prognosis in Patients with Early-Stage Lung Adenocarcinoma

Supplementary Table 4 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Supplementary Table 1 from RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma

The Long Noncoding RNA Lncnb1 Promotes Tumorigenesis by Interacting with Ribosomal Protein RPL35

Figure S1-8 from Long Noncoding RNA <i>neat1</i>, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/<b>β</b>-Catenin Pathway by Scaffolding EZH2

Supplementary Tables from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

Supplementary Table 3 from Long Noncoding RNA ANRIL Promotes Non–Small Cell Lung Cancer Cell Proliferation and Inhibits Apoptosis by Silencing KLF2 and P21 Expression

The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation.

Supplementary Data 1 from an LTR Retrotransposon-Derived Long Noncoding RNA Lncmer52a Promotes Hepatocellular Carcinoma Progression by Binding P120-Catenin

High-throughput screening identifies non-coding RNA PANC246 as a novel pan-tumor suppressor ncRNA

Supplementary files from An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin

Supplementary Table S1 from Long Noncoding RNA Pancets-1 Promotes Neuroblastoma Progression Through Hnrnpk-Mediated Β-Catenin Stabilization

Supplementary Table S2 from Long Noncoding RNA Pancets-1 Promotes Neuroblastoma Progression Through Hnrnpk-Mediated Β-Catenin Stabilization

Supplementary Figure S1-S5 from Long Noncoding RNA Pancets-1 Promotes Neuroblastoma Progression Through Hnrnpk-Mediated Β-Catenin Stabilization

Supplementary Tables from LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen–Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation

Supplementary Table 7-10 from Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2

Supplementary Table 1-4 from Long Noncoding RNA &lt;i&gt;neat1&lt;/i&gt;, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/&lt;b&gt;β&lt;/b&gt;-Catenin Pathway by Scaffolding EZH2

Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Long Noncoding RNA LCAT1 Functions As a Cerna to Regulate RAC1 Function by Sponging Mir-4715-5p in Lung Cancer

Supplementary Table 1 from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by <i>LKB1</i> Loss

A Novel Neutrophil Extracellular Traps-Related Lncrna Signature Predicts Prognosis in Patients with Early-Stage Lung Adenocarcinoma

Supplementary Table 4 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Supplementary Table 1 from RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma

The Long Noncoding RNA Lncnb1 Promotes Tumorigenesis by Interacting with Ribosomal Protein RPL35

Figure S1-8 from Long Noncoding RNA &lt;i&gt;neat1&lt;/i&gt;, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/&lt;b&gt;β&lt;/b&gt;-Catenin Pathway by Scaffolding EZH2

Supplementary Tables from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

Supplementary Table 3 from Long Noncoding RNA ANRIL Promotes Non–Small Cell Lung Cancer Cell Proliferation and Inhibits Apoptosis by Silencing KLF2 and P21 Expression

The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation.

Supplementary Data 1 from an LTR Retrotransposon-Derived Long Noncoding RNA Lncmer52a Promotes Hepatocellular Carcinoma Progression by Binding P120-Catenin

High-throughput screening identifies non-coding RNA PANC246 as a novel pan-tumor suppressor ncRNA

Supplementary files from An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin

Supplementary Table 1-4 from Long Noncoding RNA <i>neat1</i>, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/<b>β</b>-Catenin Pathway by Scaffolding EZH2

Figure S1-8 from Long Noncoding RNA <i>neat1</i>, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/<b>β</b>-Catenin Pathway by Scaffolding EZH2